Search results
Results from the WOW.Com Content Network
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids.
Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with opioid use disorder (OUD). [1] In the case of methadone maintenance treatment (MMT), methadone is used to treat dependence on heroin or other opioids, and is administered on an ongoing basis.
Screening large numbers of individuals present an opportunity to engage those who are in need of treatment and refer them to correct resources. Efforts to provide an evidence base for alcohol screening and brief intervention in primary health care settings have been started since the 1980s in the US and the World Health Organization. [9]
Substance use disorder (SUD) is the persistent use of drugs despite substantial harm and adverse consequences to self and others. [8] Related terms include substance use problems [ 9 ] and problematic drug or alcohol use.
The Dalai Lama, the exiled spiritual leader of Tibetan Buddhism, arrived in New York on Sunday ahead of medical treatment for his knees and was greeted by hundreds of cheering and chanting supporters.
Dual diagnosis (also called co-occurring disorders (COD) or dual pathology) [1] [2] is the condition of having a mental illness and a comorbid substance use disorder.There is considerable debate surrounding the appropriateness of using a single category for a heterogeneous group of individuals with complex needs and a varied range of problems.
The SUDS may be used as a benchmark for a professional or observer to evaluate the progress of treatment. In desensitization-based therapies, such as those listed below, the patients' regular self assessments enable them to guide the clinician repeatedly as part of the therapeutic dialog. [2] The SUD-level was developed by Joseph Wolpe in 1969. [3]
The new $7.6 million 2,500-square-foot laboratory was funded by New York State investment and will house clinical experts from State University of New York institutions who will collaborate on cutting-edge research of Coronavirus, Lyme, West Nile, Zika, Dengue, and other infectious diseases. The VBL also features a Human Challenge Room, where a ...